The Sackler family will now relinquish control of Purdue Pharma and cease sale of opioids in the U.S. as part of a $7.4 billion settlement.

Purdue Pharma has won support from the attorneys general of 55 U.S. states and territories for its $7.4 billion settlement to ...

Purdue Pharma and Sackler family members who own the company have reached a $7.4 billion settlement with all 50 states and U.S. territories over the company's improper marketing of opioids.

A member of the Sackler family, which owns OxyContin-maker Purdue Pharma, expressed "sadness" over the nation's opioid epidemic during a congressional hearing Thursday that marked the first time ...

Purdue Pharma and its owners, the Sackler family, are set to pay $7.4 billion to settle lawsuits regarding the drug company’s manufacturing and distribution of opioids. The Sackler family and ...

Purdue Pharma headquarters in Stamford, Conn., is shown on Oct. 21. Two members of the Sackler family agreed to make a rare public appearance to take questions from a congressional committee that ...

Arkansas will receive $44.5 million annually for 17 years as part of a settlement with Purdue Pharma and the Sackler family, with one-third of the funds allocated to the state and the remaining ...

Fifty-five attorneys general around the country have now signed on to a $7.4 billion settlement with drugmaker Purdue Pharma and its owners, the Sackler family, over the opioid crisis, officials said.

A narrowly divided Supreme Court in a 5-4 decision struck down a hard-fought bankruptcy plan for OxyContin manufacturer Purdue Pharma that would have awarded $6 billion to state and local ...

Purdue Pharma’s $7B opioid settlement could advance after states back it The deal calls for members of the Sackler family who own the company to give up ownership and to contribute up to $7 ...